HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[High-dose intravenous immunoglobulin treatment].

Abstract
High-dose intravenous immunoglobulin (VIG) treatment for the acute stage of Kawasaki disease (KD) has shown to be effective and safe. But it is known that 15% to 20% of patients are resistant to initial MG. Initial VIG treatment (2 g/kg) and aspirin (30-50 mg/kg/day) within 9th day of illness has a potentially risk of coronary arterial lesions. It should be mentioned that prediction of resistant cases in IVIG with KD can be detected by information from patients before and early after start of treatment. Some scoring systems are available for the prediction.
AuthorsZenji Nonaka
JournalNihon rinsho. Japanese journal of clinical medicine (Nihon Rinsho) Vol. 66 Issue 2 Pg. 327-31 (Feb 2008) ISSN: 0047-1852 [Print] Japan
PMID18260332 (Publication Type: English Abstract, Journal Article, Review)
Chemical References
  • Immunoglobulins, Intravenous
Topics
  • Child, Preschool
  • Fluid Therapy
  • Humans
  • Immunoglobulins, Intravenous (administration & dosage, adverse effects)
  • Infant
  • Mucocutaneous Lymph Node Syndrome (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: